Product Description
This digital document is an article from Internal Medicine News, published by International Medical News Group on February 1, 2010. The length of the article is 2075 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Case study: colesevelam hydrochloride for mar patient with type 2 diabetes mellitus and hyperlipidemia.(Case study)
Author: Peter H. Jones
Publication: Internal Medicine News (Magazine/Journal)
Date: February 1, 2010
Publisher: International Medical News Group
Volume: 43Issue: 2Page: 13(1)

Article Type: Case study

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description

Primary care physicians and allied providers need to have a thorough understanding of the evaluation of cardiac risk and the treatment of dyslipidemias. Cholesterol is the primary target of treatment for cardiovascular risk reduction. Primary care providers must first be able to calculate cardiac risk to categorize patients into individual risk treatment groups. A large number of clinical trials and treatment guidelines and recommendations have been published since the last National Cholesterol Education Program (NCEP) Adult Treatment Panel recommendations were disseminated five years ago. This book will present an updated view of this confusing literature and recommendations and focus on an easy and practical way to approach cardiac risk reduction.

A major portion of the book will present a risk reduction approach to common, difficult patient types with practical recommendations. The book will begin with a discussion of cardiovascular risk evaluation that will go beyond the NCEP risk calculator. It will incorporate decision making revolving around the metabolic syndrome, biomarkers such as inflammatory markers, and the role of non-invasive atherosclerotic imaging (Calcium score, CT angiography, carotid IMT). The second section will give an overview of lipoprotein metabolism and the development of atherosclerosis. We can then discuss the role of advanced lipid testing and the inherited lipid disorders. Section three will give an overview of treatment starting with lifestyle modification and then will cover pharmacological therapy. The fourth and most important section will present specific patient examples and a very practical approach to treatment. The patient types will be common patients that the Primary Care Physician would see and difficult problems that do not easily fit the current guidelines.

The following is an outline of the chapters for the book. There are 16 chapters with each projected to be 15 - 20 pages.

Product Description
This is a AIR FORCE INST OF TECH WRIGHT-PATTERSONAFB OH report procured by the Pentagon and made available for public release. It has been reproduced in the best form available to the Pentagon. It is not spiral-bound, but rather assembled with Velobinding in a soft, white linen cover. The Storming Media report number is A040543. The abstract provided by the Pentagon follows: Annual lipid-lowering therapy costs the Department of Defense (DOD) in excess of $40 million. In 1995, a new computer system was implemented nationwide to assist in tracking medical utilization in addition to performing general operations. Pharmacy, laboratory, and patient administration records were integrated. The purpose of this study was to investigate the five currently marketed HMG-CoA reductase inhibitors (statins) in the military beneficiary population served by this computer system in a selected area. The computer records of patients receiving statin therapy between February 1996 and April 1998 were retrospectively examined: (1) to determine if statin therapy achieved reductions in low-density lipoprotein (LDL) cholesterol levels similar to those seen in clinical trials; (2) to determine if there were any differences between the five statins in the LDL reductions observed; and (3) to compare the cost- effectiveness of the five statins by using annual estimated treatment costs per one percent reduction in LDL. The perspective for the cost-effectiveness analyses was that of the military. An original sample of 4436 patients resulted in 289 final subjects meeting the criteria of being new statin users and having at least one pre- treatment and post-treatment LDL value on file. As the majority of patients received one particular statin, few comparisons could be conducted. Observed reductions in LDL for patients taking pravastatin were less than predicted by clinical trials, but with 95 percent confidence intervals, approached the predicted values. ... Read more

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on April 1, 2004. The length of the article is 564 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Statin model helps negate hyperlipidemia in HIV: culprit: protease inhibitors.(Clinical Rounds)
Author: Sherry Boschert
Publication: Family Practice News (Magazine/Journal)
Date: April 1, 2004
Publisher: International Medical News Group
Volume: 34Issue: 7Page: 34(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Pediatric News, published by International Medical News Group on September 1, 2003. The length of the article is 367 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Vitamins C and E may help improve endothelial function: hyperlipidemia patients.(News)
Author: Doug Brunk
Publication: Pediatric News (Magazine/Journal)
Date: September 1, 2003
Publisher: International Medical News Group
Volume: 37Issue: 9Page: 5(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on January 1, 2010. The length of the article is 2029 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Case study: management decisions in a comorbid patient with type 2 diabetes having primary hyperlipidemia.(CASE STUDY)
Author: Yehuda Handelsman
Publication: Family Practice News (Magazine/Journal)
Date: January 1, 2010
Publisher: International Medical News Group
Volume: 40Issue: 1Page: 13(1)

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
This digital document is an article from Pediatric News, published by International Medical News Group on September 1, 2003. The length of the article is 446 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Omega-3 fatty acid capsules reduce endothelial dysfunction in hyperlipidemia: slow coronary heart disease progression?(News)
Author: Bruce Jancin
Publication: Pediatric News (Magazine/Journal)
Date: September 1, 2003
Publisher: International Medical News Group
Volume: 37Issue: 9Page: 5(1)

Distributed by Thomson Gale ... Read more

Product Description
This digital document is an article from Family Practice News, published by International Medical News Group on February 1, 2010. The length of the article is 2079 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Case study: Colesevelam Hydrochloride for management of a patient with type 2 diabetes mellitus and hyperlipidemia.(CASE STUDY)
Author: Peter H. Jones
Publication: Family Practice News (Magazine/Journal)
Date: February 1, 2010
Publisher: International Medical News Group
Volume: 40Issue: 2Page: 13(1)

Distributed by Gale, a part of Cengage Learning ... Read more

Product Description
Cardiovascular diseases have been life-threatening conditions to mankind for centuries. Chinese medicine has a long history in treating cardiovascular diseases. Its clinical curative effects have already been verified by a large number of clinical experiments. The researches of organic integration of biomedical techniques of the last twenty years with Chinese medicine have revealed the mechanism of Chinese medicine in treating cardiovascular diseases. This book systematically summarizes the clinical experience of treating cardiovascular disease with Chinese medicine and collects experts' clinical insights to demonstrate the highest level of Chinese medical treatments. It also covers the present clinical results achieved in treating coronary artery disease and hyperlipidemia which demonstrate superiority and characteristics of traditional Chinese medical treatment. ... Read more

Product Description
This text stresses secondary acquired hyperlipoproteinemias associated with different diseases such as diabetes, kidney disease, excess of steroids or thyroid deficiency. ... Read more

Product Description
This set of four patient education booklets sets out to explain the various aspects of the most common cardiovascular disorders through simple language and illustrations. The series covers coronary artery disease, hyperlipidaemia, heart failure and hypertension. ... Read more